nodes	percent_of_prediction	percent_of_DWPC	metapath
Remifentanil—Fentanyl—Benzphetamine—obesity	0.466	1	CrCrCtD
Remifentanil—Dysuria—Sibutramine—obesity	0.00069	0.00213	CcSEcCtD
Remifentanil—Nausea—Phendimetrazine—obesity	0.000689	0.00213	CcSEcCtD
Remifentanil—Feeling abnormal—Diethylpropion—obesity	0.00068	0.0021	CcSEcCtD
Remifentanil—Atrioventricular block—Topiramate—obesity	0.000673	0.00208	CcSEcCtD
Remifentanil—Constipation—Cimetidine—obesity	0.000671	0.00208	CcSEcCtD
Remifentanil—Renal failure—Orlistat—obesity	0.000668	0.00207	CcSEcCtD
Remifentanil—Hyperglycaemia—Sibutramine—obesity	0.000665	0.00206	CcSEcCtD
Remifentanil—Nasopharyngitis—Bupropion—obesity	0.000665	0.00206	CcSEcCtD
Remifentanil—Muscle twitching—Topiramate—obesity	0.000665	0.00206	CcSEcCtD
Remifentanil—Pneumonia—Sibutramine—obesity	0.000661	0.00205	CcSEcCtD
Remifentanil—Urticaria—Diethylpropion—obesity	0.000655	0.00203	CcSEcCtD
Remifentanil—Dizziness—Phenylpropanolamine—obesity	0.000655	0.00203	CcSEcCtD
Remifentanil—Diarrhoea—Phentermine—obesity	0.000649	0.00201	CcSEcCtD
Remifentanil—Feeling abnormal—Cimetidine—obesity	0.000647	0.002	CcSEcCtD
Remifentanil—Renal failure—Sibutramine—obesity	0.000646	0.002	CcSEcCtD
Remifentanil—Dysphagia—Bupropion—obesity	0.000643	0.00199	CcSEcCtD
Remifentanil—Bronchospasm—Bupropion—obesity	0.000632	0.00196	CcSEcCtD
Remifentanil—Urinary incontinence—Topiramate—obesity	0.000631	0.00195	CcSEcCtD
Remifentanil—Sweating—Sibutramine—obesity	0.00063	0.00195	CcSEcCtD
Remifentanil—Vomiting—Phenylpropanolamine—obesity	0.00063	0.00195	CcSEcCtD
Remifentanil—Dizziness—Phentermine—obesity	0.000627	0.00194	CcSEcCtD
Remifentanil—Haematuria—Sibutramine—obesity	0.000627	0.00194	CcSEcCtD
Remifentanil—Rash—Phenylpropanolamine—obesity	0.000625	0.00193	CcSEcCtD
Remifentanil—Dermatitis—Phenylpropanolamine—obesity	0.000624	0.00193	CcSEcCtD
Remifentanil—Body temperature increased—Cimetidine—obesity	0.000621	0.00192	CcSEcCtD
Remifentanil—Bronchitis—Bupropion—obesity	0.000618	0.00191	CcSEcCtD
Remifentanil—Abdominal discomfort—Bupropion—obesity	0.000616	0.00191	CcSEcCtD
Remifentanil—Haemoglobin—Orlistat—obesity	0.000613	0.0019	CcSEcCtD
Remifentanil—Haemorrhage—Orlistat—obesity	0.00061	0.00189	CcSEcCtD
Remifentanil—Pharyngitis—Orlistat—obesity	0.000605	0.00187	CcSEcCtD
Remifentanil—Vomiting—Phentermine—obesity	0.000603	0.00186	CcSEcCtD
Remifentanil—Dysuria—Bupropion—obesity	0.000601	0.00186	CcSEcCtD
Remifentanil—Bradycardia—Sibutramine—obesity	0.000601	0.00186	CcSEcCtD
Remifentanil—Rash—Phentermine—obesity	0.000598	0.00185	CcSEcCtD
Remifentanil—Dermatitis—Phentermine—obesity	0.000597	0.00185	CcSEcCtD
Remifentanil—Headache—Phentermine—obesity	0.000594	0.00184	CcSEcCtD
Remifentanil—Haemoglobin—Sibutramine—obesity	0.000593	0.00184	CcSEcCtD
Remifentanil—Haemorrhage—Sibutramine—obesity	0.00059	0.00183	CcSEcCtD
Remifentanil—Nausea—Phenylpropanolamine—obesity	0.000589	0.00182	CcSEcCtD
Remifentanil—Pharyngitis—Sibutramine—obesity	0.000586	0.00181	CcSEcCtD
Remifentanil—Hyperglycaemia—Bupropion—obesity	0.00058	0.00179	CcSEcCtD
Remifentanil—Hypersensitivity—Cimetidine—obesity	0.000578	0.00179	CcSEcCtD
Remifentanil—Pneumonia—Bupropion—obesity	0.000577	0.00178	CcSEcCtD
Remifentanil—Visual impairment—Sibutramine—obesity	0.000569	0.00176	CcSEcCtD
Remifentanil—Diarrhoea—Diethylpropion—obesity	0.000565	0.00175	CcSEcCtD
Remifentanil—Nausea—Phentermine—obesity	0.000563	0.00174	CcSEcCtD
Remifentanil—Immune system disorder—Orlistat—obesity	0.000551	0.0017	CcSEcCtD
Remifentanil—Mediastinal disorder—Orlistat—obesity	0.00055	0.0017	CcSEcCtD
Remifentanil—Sweating—Bupropion—obesity	0.00055	0.0017	CcSEcCtD
Remifentanil—Sleep disorder—Topiramate—obesity	0.000548	0.00169	CcSEcCtD
Remifentanil—Dizziness—Diethylpropion—obesity	0.000546	0.00169	CcSEcCtD
Remifentanil—Diarrhoea—Cimetidine—obesity	0.000537	0.00166	CcSEcCtD
Remifentanil—Angiopathy—Sibutramine—obesity	0.000536	0.00166	CcSEcCtD
Remifentanil—Immune system disorder—Sibutramine—obesity	0.000533	0.00165	CcSEcCtD
Remifentanil—Disorientation—Topiramate—obesity	0.00053	0.00164	CcSEcCtD
Remifentanil—Chills—Sibutramine—obesity	0.00053	0.00164	CcSEcCtD
Remifentanil—Arrhythmia—Sibutramine—obesity	0.000527	0.00163	CcSEcCtD
Remifentanil—Vomiting—Diethylpropion—obesity	0.000525	0.00162	CcSEcCtD
Remifentanil—Nasal congestion—Topiramate—obesity	0.00052	0.00161	CcSEcCtD
Remifentanil—Rash—Diethylpropion—obesity	0.00052	0.00161	CcSEcCtD
Remifentanil—Dermatitis—Diethylpropion—obesity	0.00052	0.00161	CcSEcCtD
Remifentanil—Dizziness—Cimetidine—obesity	0.000519	0.00161	CcSEcCtD
Remifentanil—Haemoglobin—Bupropion—obesity	0.000517	0.0016	CcSEcCtD
Remifentanil—Headache—Diethylpropion—obesity	0.000517	0.0016	CcSEcCtD
Remifentanil—Haemorrhage—Bupropion—obesity	0.000515	0.00159	CcSEcCtD
Remifentanil—Hallucination—Bupropion—obesity	0.000512	0.00158	CcSEcCtD
Remifentanil—Pharyngitis—Bupropion—obesity	0.000511	0.00158	CcSEcCtD
Remifentanil—Amnesia—Topiramate—obesity	0.000505	0.00156	CcSEcCtD
Remifentanil—Visual disturbance—Topiramate—obesity	0.0005	0.00155	CcSEcCtD
Remifentanil—Vomiting—Cimetidine—obesity	0.000499	0.00154	CcSEcCtD
Remifentanil—Visual impairment—Bupropion—obesity	0.000496	0.00153	CcSEcCtD
Remifentanil—Rash—Cimetidine—obesity	0.000495	0.00153	CcSEcCtD
Remifentanil—Dermatitis—Cimetidine—obesity	0.000495	0.00153	CcSEcCtD
Remifentanil—Headache—Cimetidine—obesity	0.000492	0.00152	CcSEcCtD
Remifentanil—Nausea—Diethylpropion—obesity	0.00049	0.00152	CcSEcCtD
Remifentanil—Tremor—Sibutramine—obesity	0.000482	0.00149	CcSEcCtD
Remifentanil—Flushing—Bupropion—obesity	0.000478	0.00148	CcSEcCtD
Remifentanil—Cardiac disorder—Bupropion—obesity	0.000478	0.00148	CcSEcCtD
Remifentanil—Anaemia—Sibutramine—obesity	0.000475	0.00147	CcSEcCtD
Remifentanil—Agitation—Sibutramine—obesity	0.000472	0.00146	CcSEcCtD
Remifentanil—Angiopathy—Bupropion—obesity	0.000467	0.00144	CcSEcCtD
Remifentanil—Nausea—Cimetidine—obesity	0.000466	0.00144	CcSEcCtD
Remifentanil—Immune system disorder—Bupropion—obesity	0.000465	0.00144	CcSEcCtD
Remifentanil—Mediastinal disorder—Bupropion—obesity	0.000464	0.00143	CcSEcCtD
Remifentanil—Cough—Orlistat—obesity	0.000463	0.00143	CcSEcCtD
Remifentanil—Chills—Bupropion—obesity	0.000462	0.00143	CcSEcCtD
Remifentanil—Syncope—Sibutramine—obesity	0.000461	0.00143	CcSEcCtD
Remifentanil—Convulsion—Orlistat—obesity	0.00046	0.00142	CcSEcCtD
Remifentanil—Arrhythmia—Bupropion—obesity	0.00046	0.00142	CcSEcCtD
Remifentanil—Loss of consciousness—Sibutramine—obesity	0.000452	0.0014	CcSEcCtD
Remifentanil—Urinary retention—Topiramate—obesity	0.000451	0.00139	CcSEcCtD
Remifentanil—Anxiety—Orlistat—obesity	0.000451	0.00139	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Orlistat—obesity	0.000449	0.00139	CcSEcCtD
Remifentanil—Cough—Sibutramine—obesity	0.000448	0.00139	CcSEcCtD
Remifentanil—Convulsion—Sibutramine—obesity	0.000445	0.00138	CcSEcCtD
Remifentanil—Hypertension—Sibutramine—obesity	0.000444	0.00137	CcSEcCtD
Remifentanil—Dry mouth—Orlistat—obesity	0.000442	0.00137	CcSEcCtD
Remifentanil—Anxiety—Sibutramine—obesity	0.000436	0.00135	CcSEcCtD
Remifentanil—Anaphylactic shock—Orlistat—obesity	0.000433	0.00134	CcSEcCtD
Remifentanil—Oedema—Orlistat—obesity	0.000433	0.00134	CcSEcCtD
Remifentanil—Alfentanil—ALB—obesity	0.000432	0.433	CrCbGaD
Remifentanil—Hypokalaemia—Topiramate—obesity	0.000431	0.00133	CcSEcCtD
Remifentanil—Dry mouth—Sibutramine—obesity	0.000428	0.00132	CcSEcCtD
Remifentanil—Nervous system disorder—Orlistat—obesity	0.000425	0.00131	CcSEcCtD
Remifentanil—Nasopharyngitis—Topiramate—obesity	0.000424	0.00131	CcSEcCtD
Remifentanil—Confusional state—Sibutramine—obesity	0.000423	0.00131	CcSEcCtD
Remifentanil—Skin disorder—Orlistat—obesity	0.000421	0.0013	CcSEcCtD
Remifentanil—Tremor—Bupropion—obesity	0.00042	0.0013	CcSEcCtD
Remifentanil—Anaphylactic shock—Sibutramine—obesity	0.000419	0.0013	CcSEcCtD
Remifentanil—Oedema—Sibutramine—obesity	0.000419	0.0013	CcSEcCtD
Remifentanil—Hyperhidrosis—Orlistat—obesity	0.000419	0.0013	CcSEcCtD
Remifentanil—Anaemia—Bupropion—obesity	0.000414	0.00128	CcSEcCtD
Remifentanil—Shock—Sibutramine—obesity	0.000413	0.00128	CcSEcCtD
Remifentanil—Agitation—Bupropion—obesity	0.000412	0.00127	CcSEcCtD
Remifentanil—Thrombocytopenia—Sibutramine—obesity	0.000411	0.00127	CcSEcCtD
Remifentanil—Dysphagia—Topiramate—obesity	0.00041	0.00127	CcSEcCtD
Remifentanil—Tachycardia—Sibutramine—obesity	0.000409	0.00127	CcSEcCtD
Remifentanil—Skin disorder—Sibutramine—obesity	0.000407	0.00126	CcSEcCtD
Remifentanil—Hyperhidrosis—Sibutramine—obesity	0.000405	0.00125	CcSEcCtD
Remifentanil—Syncope—Bupropion—obesity	0.000402	0.00124	CcSEcCtD
Remifentanil—Bronchitis—Topiramate—obesity	0.000394	0.00122	CcSEcCtD
Remifentanil—Loss of consciousness—Bupropion—obesity	0.000394	0.00122	CcSEcCtD
Remifentanil—Abdominal discomfort—Topiramate—obesity	0.000393	0.00121	CcSEcCtD
Remifentanil—Hypotension—Sibutramine—obesity	0.000392	0.00121	CcSEcCtD
Remifentanil—Cough—Bupropion—obesity	0.000391	0.00121	CcSEcCtD
Remifentanil—Paraesthesia—Orlistat—obesity	0.000389	0.0012	CcSEcCtD
Remifentanil—Convulsion—Bupropion—obesity	0.000388	0.0012	CcSEcCtD
Remifentanil—Hypertension—Bupropion—obesity	0.000387	0.0012	CcSEcCtD
Remifentanil—Dysuria—Topiramate—obesity	0.000383	0.00118	CcSEcCtD
Remifentanil—Dyspepsia—Orlistat—obesity	0.000382	0.00118	CcSEcCtD
Remifentanil—Anxiety—Bupropion—obesity	0.00038	0.00118	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Bupropion—obesity	0.000379	0.00117	CcSEcCtD
Remifentanil—Paraesthesia—Sibutramine—obesity	0.000377	0.00116	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Orlistat—obesity	0.000374	0.00116	CcSEcCtD
Remifentanil—Dyspnoea—Sibutramine—obesity	0.000374	0.00116	CcSEcCtD
Remifentanil—Dry mouth—Bupropion—obesity	0.000373	0.00115	CcSEcCtD
Remifentanil—Somnolence—Sibutramine—obesity	0.000373	0.00115	CcSEcCtD
Remifentanil—Pain—Orlistat—obesity	0.000371	0.00115	CcSEcCtD
Remifentanil—Pethidine—SLC6A4—obesity	0.000371	0.371	CrCbGaD
Remifentanil—Hyperglycaemia—Topiramate—obesity	0.00037	0.00114	CcSEcCtD
Remifentanil—Dyspepsia—Sibutramine—obesity	0.000369	0.00114	CcSEcCtD
Remifentanil—Confusional state—Bupropion—obesity	0.000369	0.00114	CcSEcCtD
Remifentanil—Pneumonia—Topiramate—obesity	0.000367	0.00114	CcSEcCtD
Remifentanil—Anaphylactic shock—Bupropion—obesity	0.000366	0.00113	CcSEcCtD
Remifentanil—Oedema—Bupropion—obesity	0.000366	0.00113	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Sibutramine—obesity	0.000362	0.00112	CcSEcCtD
Remifentanil—Shock—Bupropion—obesity	0.00036	0.00111	CcSEcCtD
Remifentanil—Renal failure—Topiramate—obesity	0.000359	0.00111	CcSEcCtD
Remifentanil—Constipation—Sibutramine—obesity	0.000359	0.00111	CcSEcCtD
Remifentanil—Pain—Sibutramine—obesity	0.000359	0.00111	CcSEcCtD
Remifentanil—Nervous system disorder—Bupropion—obesity	0.000359	0.00111	CcSEcCtD
Remifentanil—Thrombocytopenia—Bupropion—obesity	0.000358	0.00111	CcSEcCtD
Remifentanil—Feeling abnormal—Orlistat—obesity	0.000357	0.0011	CcSEcCtD
Remifentanil—Tachycardia—Bupropion—obesity	0.000357	0.0011	CcSEcCtD
Remifentanil—Skin disorder—Bupropion—obesity	0.000355	0.0011	CcSEcCtD
Remifentanil—Hyperhidrosis—Bupropion—obesity	0.000353	0.00109	CcSEcCtD
Remifentanil—Haematuria—Topiramate—obesity	0.000348	0.00108	CcSEcCtD
Remifentanil—Feeling abnormal—Sibutramine—obesity	0.000346	0.00107	CcSEcCtD
Remifentanil—Urticaria—Orlistat—obesity	0.000344	0.00106	CcSEcCtD
Remifentanil—Body temperature increased—Orlistat—obesity	0.000343	0.00106	CcSEcCtD
Remifentanil—Hypotension—Bupropion—obesity	0.000342	0.00106	CcSEcCtD
Remifentanil—Bradycardia—Topiramate—obesity	0.000334	0.00103	CcSEcCtD
Remifentanil—Urticaria—Sibutramine—obesity	0.000333	0.00103	CcSEcCtD
Remifentanil—Body temperature increased—Sibutramine—obesity	0.000332	0.00103	CcSEcCtD
Remifentanil—Haemoglobin—Topiramate—obesity	0.00033	0.00102	CcSEcCtD
Remifentanil—Paraesthesia—Bupropion—obesity	0.000328	0.00102	CcSEcCtD
Remifentanil—Haemorrhage—Topiramate—obesity	0.000328	0.00101	CcSEcCtD
Remifentanil—Hallucination—Topiramate—obesity	0.000326	0.00101	CcSEcCtD
Remifentanil—Dyspnoea—Bupropion—obesity	0.000326	0.00101	CcSEcCtD
Remifentanil—Pharyngitis—Topiramate—obesity	0.000325	0.00101	CcSEcCtD
Remifentanil—Somnolence—Bupropion—obesity	0.000325	0.00101	CcSEcCtD
Remifentanil—Dyspepsia—Bupropion—obesity	0.000322	0.000996	CcSEcCtD
Remifentanil—Hypersensitivity—Orlistat—obesity	0.000319	0.000988	CcSEcCtD
Remifentanil—Visual impairment—Topiramate—obesity	0.000316	0.000977	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Bupropion—obesity	0.000316	0.000976	CcSEcCtD
Remifentanil—Pain—Bupropion—obesity	0.000313	0.000967	CcSEcCtD
Remifentanil—Constipation—Bupropion—obesity	0.000313	0.000967	CcSEcCtD
Remifentanil—Hypersensitivity—Sibutramine—obesity	0.000309	0.000956	CcSEcCtD
Remifentanil—Pruritus—Orlistat—obesity	0.000307	0.000948	CcSEcCtD
Remifentanil—Cardiac disorder—Topiramate—obesity	0.000304	0.000941	CcSEcCtD
Remifentanil—Flushing—Topiramate—obesity	0.000304	0.000941	CcSEcCtD
Remifentanil—Feeling abnormal—Bupropion—obesity	0.000301	0.000932	CcSEcCtD
Remifentanil—Angiopathy—Topiramate—obesity	0.000298	0.00092	CcSEcCtD
Remifentanil—Pruritus—Sibutramine—obesity	0.000297	0.000918	CcSEcCtD
Remifentanil—Diarrhoea—Orlistat—obesity	0.000297	0.000917	CcSEcCtD
Remifentanil—Immune system disorder—Topiramate—obesity	0.000296	0.000916	CcSEcCtD
Remifentanil—Mediastinal disorder—Topiramate—obesity	0.000296	0.000914	CcSEcCtD
Remifentanil—Chills—Topiramate—obesity	0.000294	0.00091	CcSEcCtD
Remifentanil—Urticaria—Bupropion—obesity	0.00029	0.000898	CcSEcCtD
Remifentanil—Body temperature increased—Bupropion—obesity	0.000289	0.000894	CcSEcCtD
Remifentanil—Diarrhoea—Sibutramine—obesity	0.000287	0.000888	CcSEcCtD
Remifentanil—Dizziness—Orlistat—obesity	0.000287	0.000886	CcSEcCtD
Remifentanil—Erythema—Topiramate—obesity	0.000285	0.000883	CcSEcCtD
Remifentanil—Dizziness—Sibutramine—obesity	0.000277	0.000858	CcSEcCtD
Remifentanil—Vomiting—Orlistat—obesity	0.000276	0.000852	CcSEcCtD
Remifentanil—Rash—Orlistat—obesity	0.000273	0.000845	CcSEcCtD
Remifentanil—Dermatitis—Orlistat—obesity	0.000273	0.000844	CcSEcCtD
Remifentanil—Headache—Orlistat—obesity	0.000272	0.00084	CcSEcCtD
Remifentanil—Hypersensitivity—Bupropion—obesity	0.000269	0.000833	CcSEcCtD
Remifentanil—Tremor—Topiramate—obesity	0.000267	0.000827	CcSEcCtD
Remifentanil—Vomiting—Sibutramine—obesity	0.000267	0.000825	CcSEcCtD
Remifentanil—Rash—Sibutramine—obesity	0.000264	0.000818	CcSEcCtD
Remifentanil—Dermatitis—Sibutramine—obesity	0.000264	0.000817	CcSEcCtD
Remifentanil—Anaemia—Topiramate—obesity	0.000264	0.000816	CcSEcCtD
Remifentanil—Headache—Sibutramine—obesity	0.000263	0.000813	CcSEcCtD
Remifentanil—Agitation—Topiramate—obesity	0.000262	0.000811	CcSEcCtD
Remifentanil—Pruritus—Bupropion—obesity	0.000259	0.0008	CcSEcCtD
Remifentanil—Nausea—Orlistat—obesity	0.000257	0.000796	CcSEcCtD
Remifentanil—Syncope—Topiramate—obesity	0.000256	0.000792	CcSEcCtD
Remifentanil—Loss of consciousness—Topiramate—obesity	0.000251	0.000776	CcSEcCtD
Remifentanil—Diarrhoea—Bupropion—obesity	0.00025	0.000774	CcSEcCtD
Remifentanil—Nausea—Sibutramine—obesity	0.000249	0.000771	CcSEcCtD
Remifentanil—Cough—Topiramate—obesity	0.000249	0.00077	CcSEcCtD
Remifentanil—Convulsion—Topiramate—obesity	0.000247	0.000765	CcSEcCtD
Remifentanil—Hypertension—Topiramate—obesity	0.000246	0.000762	CcSEcCtD
Remifentanil—Anxiety—Topiramate—obesity	0.000242	0.000749	CcSEcCtD
Remifentanil—Dizziness—Bupropion—obesity	0.000242	0.000748	CcSEcCtD
Remifentanil—Unspecified disorder of skin and subcutaneous tissue—Topiramate—obesity	0.000241	0.000746	CcSEcCtD
Remifentanil—Dry mouth—Topiramate—obesity	0.000238	0.000735	CcSEcCtD
Remifentanil—Confusional state—Topiramate—obesity	0.000235	0.000727	CcSEcCtD
Remifentanil—Oedema—Topiramate—obesity	0.000233	0.000721	CcSEcCtD
Remifentanil—Vomiting—Bupropion—obesity	0.000232	0.000719	CcSEcCtD
Remifentanil—Rash—Bupropion—obesity	0.000231	0.000713	CcSEcCtD
Remifentanil—Dermatitis—Bupropion—obesity	0.00023	0.000712	CcSEcCtD
Remifentanil—Shock—Topiramate—obesity	0.000229	0.000709	CcSEcCtD
Remifentanil—Headache—Bupropion—obesity	0.000229	0.000708	CcSEcCtD
Remifentanil—Nervous system disorder—Topiramate—obesity	0.000228	0.000707	CcSEcCtD
Remifentanil—Thrombocytopenia—Topiramate—obesity	0.000228	0.000705	CcSEcCtD
Remifentanil—Tachycardia—Topiramate—obesity	0.000227	0.000703	CcSEcCtD
Remifentanil—Skin disorder—Topiramate—obesity	0.000226	0.0007	CcSEcCtD
Remifentanil—Hyperhidrosis—Topiramate—obesity	0.000225	0.000697	CcSEcCtD
Remifentanil—Hypotension—Topiramate—obesity	0.000218	0.000673	CcSEcCtD
Remifentanil—Nausea—Bupropion—obesity	0.000217	0.000672	CcSEcCtD
Remifentanil—Paraesthesia—Topiramate—obesity	0.000209	0.000647	CcSEcCtD
Remifentanil—Dyspnoea—Topiramate—obesity	0.000208	0.000642	CcSEcCtD
Remifentanil—Somnolence—Topiramate—obesity	0.000207	0.000641	CcSEcCtD
Remifentanil—Dyspepsia—Topiramate—obesity	0.000205	0.000634	CcSEcCtD
Remifentanil—Gastrointestinal disorder—Topiramate—obesity	0.000201	0.000622	CcSEcCtD
Remifentanil—Pain—Topiramate—obesity	0.000199	0.000616	CcSEcCtD
Remifentanil—Constipation—Topiramate—obesity	0.000199	0.000616	CcSEcCtD
Remifentanil—Pethidine—ALB—obesity	0.000195	0.195	CrCbGaD
Remifentanil—Feeling abnormal—Topiramate—obesity	0.000192	0.000594	CcSEcCtD
Remifentanil—Urticaria—Topiramate—obesity	0.000185	0.000572	CcSEcCtD
Remifentanil—Body temperature increased—Topiramate—obesity	0.000184	0.00057	CcSEcCtD
Remifentanil—Hypersensitivity—Topiramate—obesity	0.000172	0.000531	CcSEcCtD
Remifentanil—Pruritus—Topiramate—obesity	0.000165	0.00051	CcSEcCtD
Remifentanil—Diarrhoea—Topiramate—obesity	0.000159	0.000493	CcSEcCtD
Remifentanil—Dizziness—Topiramate—obesity	0.000154	0.000476	CcSEcCtD
Remifentanil—Vomiting—Topiramate—obesity	0.000148	0.000458	CcSEcCtD
Remifentanil—Rash—Topiramate—obesity	0.000147	0.000454	CcSEcCtD
Remifentanil—Dermatitis—Topiramate—obesity	0.000147	0.000454	CcSEcCtD
Remifentanil—Headache—Topiramate—obesity	0.000146	0.000451	CcSEcCtD
Remifentanil—Nausea—Topiramate—obesity	0.000138	0.000428	CcSEcCtD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CG—obesity	3.66e-05	0.000174	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PARP1—obesity	3.62e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GHRL—obesity	3.62e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—POMC—obesity	3.61e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRL—obesity	3.6e-05	0.000172	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPY—obesity	3.6e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD4—obesity	3.59e-05	0.000171	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IAPP—obesity	3.57e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOC3—obesity	3.57e-05	0.00017	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STK11—obesity	3.55e-05	0.000169	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—CCL2—obesity	3.53e-05	0.000168	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PLG—obesity	3.51e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—RHOA—obesity	3.5e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AGT—obesity	3.5e-05	0.000167	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—POMC—obesity	3.49e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PRKCB—obesity	3.47e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—F2—obesity	3.47e-05	0.000166	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT2—obesity	3.47e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CRH—obesity	3.47e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR1B—obesity	3.47e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3R1—obesity	3.47e-05	0.000165	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SDC1—obesity	3.43e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CNR1—obesity	3.43e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FOXO3—obesity	3.42e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCD—obesity	3.42e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ADRB2—obesity	3.42e-05	0.000163	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKR1C3—obesity	3.38e-05	0.000161	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TCF7L2—obesity	3.37e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS1—obesity	3.36e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT2—obesity	3.35e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—HTR2A—obesity	3.35e-05	0.00016	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—C3—obesity	3.34e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—DRD2—obesity	3.34e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CD—obesity	3.33e-05	0.000159	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CG—obesity	3.33e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SOCS3—obesity	3.32e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GCG—obesity	3.31e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PTPN1—obesity	3.31e-05	0.000158	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NPS—obesity	3.29e-05	0.000157	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNB3—obesity	3.25e-05	0.000155	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PRKCB—obesity	3.23e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—F2—obesity	3.23e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD1—obesity	3.23e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2C—obesity	3.23e-05	0.000154	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CD—obesity	3.22e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—TYK2—obesity	3.21e-05	0.000153	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CB—obesity	3.2e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF2—obesity	3.19e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—RHOA—obesity	3.18e-05	0.000152	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AGT—obesity	3.18e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—GNAS—obesity	3.17e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—POMC—obesity	3.17e-05	0.000151	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRL—obesity	3.16e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3R1—obesity	3.15e-05	0.00015	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NTRK2—obesity	3.14e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB1—obesity	3.12e-05	0.000149	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STK11—obesity	3.11e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOB—obesity	3.1e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—CCL2—obesity	3.1e-05	0.000148	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CG—obesity	3.09e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PLG—obesity	3.08e-05	0.000147	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—RHOA—obesity	3.07e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GHRL—obesity	3.06e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PARP1—obesity	3.06e-05	0.000146	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT2—obesity	3.04e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3R1—obesity	3.04e-05	0.000145	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD4—obesity	3.03e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL5—obesity	3.03e-05	0.000144	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FOXO3—obesity	3e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ADRB2—obesity	2.99e-05	0.000143	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LPL—obesity	2.96e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS1—obesity	2.95e-05	0.000141	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—POMC—obesity	2.95e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—FOXO1—obesity	2.94e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—F2—obesity	2.94e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PRKCB—obesity	2.94e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RPS6KB1—obesity	2.93e-05	0.00014	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CD—obesity	2.92e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SOCS3—obesity	2.91e-05	0.000139	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CB—obesity	2.91e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CNR1—obesity	2.9e-05	0.000138	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNB3—obesity	2.85e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TCF7L2—obesity	2.84e-05	0.000136	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT2—obesity	2.83e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—DRD2—obesity	2.83e-05	0.000135	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—TYK2—obesity	2.81e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CG—obesity	2.81e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CB—obesity	2.81e-05	0.000134	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF2—obesity	2.8e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PTPN1—obesity	2.8e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GCG—obesity	2.8e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—RHOA—obesity	2.79e-05	0.000133	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—GNAS—obesity	2.78e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3R1—obesity	2.76e-05	0.000132	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCD—obesity	2.73e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CD—obesity	2.72e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOB—obesity	2.72e-05	0.00013	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—POMC—obesity	2.68e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—HTR2A—obesity	2.67e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRL—obesity	2.67e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—C3—obesity	2.67e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL5—obesity	2.66e-05	0.000127	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STK11—obesity	2.63e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—CCL2—obesity	2.62e-05	0.000125	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PLG—obesity	2.6e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LPL—obesity	2.6e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—RHOA—obesity	2.6e-05	0.000124	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—FOXO1—obesity	2.58e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RPS6KB1—obesity	2.57e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT2—obesity	2.57e-05	0.000123	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3R1—obesity	2.57e-05	0.000122	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CB—obesity	2.55e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FOXO3—obesity	2.54e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS2—obesity	2.54e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AGT—obesity	2.53e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ADRB2—obesity	2.53e-05	0.000121	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS1—obesity	2.49e-05	0.000119	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—LEP—obesity	2.48e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOE—obesity	2.48e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CD—obesity	2.47e-05	0.000118	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SOCS3—obesity	2.46e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CAV1—obesity	2.46e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—APOA1—obesity	2.45e-05	0.000117	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNB3—obesity	2.41e-05	0.000115	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCD—obesity	2.39e-05	0.000114	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—TYK2—obesity	2.38e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CB—obesity	2.37e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—ESR1—obesity	2.37e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF2—obesity	2.37e-05	0.000113	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—RHOA—obesity	2.36e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—GNAS—obesity	2.35e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—HTR2A—obesity	2.34e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PRKCB—obesity	2.34e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—F2—obesity	2.34e-05	0.000112	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—C3—obesity	2.34e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3R1—obesity	2.33e-05	0.000111	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—BAD—obesity	2.31e-05	0.00011	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOB—obesity	2.3e-05	0.000109	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL5—obesity	2.24e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CG—obesity	2.24e-05	0.000107	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS2—obesity	2.22e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AGT—obesity	2.22e-05	0.000106	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IRS1—obesity	2.21e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LPL—obesity	2.19e-05	0.000105	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—FOXO1—obesity	2.18e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—LEP—obesity	2.18e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOE—obesity	2.18e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RPS6KB1—obesity	2.17e-05	0.000104	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CAV1—obesity	2.16e-05	0.000103	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CB—obesity	2.15e-05	0.000103	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—APOA1—obesity	2.15e-05	0.000103	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—POMC—obesity	2.13e-05	0.000102	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—INS—obesity	2.12e-05	0.000101	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—CCL2—obesity	2.09e-05	9.94e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—ESR1—obesity	2.08e-05	9.9e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PRKCB—obesity	2.05e-05	9.78e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—F2—obesity	2.05e-05	9.78e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IGF1—obesity	2.05e-05	9.77e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT2—obesity	2.05e-05	9.76e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—BAD—obesity	2.03e-05	9.66e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCD—obesity	2.02e-05	9.63e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—HTR2A—obesity	1.98e-05	9.43e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—C3—obesity	1.98e-05	9.41e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CD—obesity	1.97e-05	9.38e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CG—obesity	1.96e-05	9.36e-05	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—PIK3CA—obesity	1.95e-05	9.29e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—SERPINE1—obesity	1.95e-05	9.28e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IRS1—obesity	1.94e-05	9.25e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TYK2—obesity	1.89e-05	9.03e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS2—obesity	1.88e-05	8.96e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—RHOA—obesity	1.88e-05	8.95e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AGT—obesity	1.88e-05	8.94e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—POMC—obesity	1.87e-05	8.91e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—NOS3—obesity	1.86e-05	8.86e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3R1—obesity	1.86e-05	8.86e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—INS—obesity	1.86e-05	8.86e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOE—obesity	1.84e-05	8.76e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—LEP—obesity	1.84e-05	8.76e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—CCL2—obesity	1.83e-05	8.72e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CAV1—obesity	1.82e-05	8.68e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—APOA1—obesity	1.82e-05	8.66e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IGF1—obesity	1.8e-05	8.57e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT2—obesity	1.8e-05	8.56e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—PIK3CA—obesity	1.77e-05	8.44e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—ESR1—obesity	1.76e-05	8.37e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PRKCB—obesity	1.73e-05	8.26e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—F2—obesity	1.73e-05	8.26e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CD—obesity	1.73e-05	8.23e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MTOR—obesity	1.72e-05	8.18e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CB—obesity	1.72e-05	8.18e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—BAD—obesity	1.71e-05	8.17e-05	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—PIK3CA—obesity	1.71e-05	8.15e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—SERPINE1—obesity	1.71e-05	8.14e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TYK2—obesity	1.66e-05	7.91e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CG—obesity	1.66e-05	7.91e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—RHOA—obesity	1.65e-05	7.85e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IRS1—obesity	1.64e-05	7.82e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3R1—obesity	1.63e-05	7.77e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—NOS3—obesity	1.63e-05	7.77e-05	CbGpPWpGaD
Remifentanil—OPRD1—GPCR downstream signaling—AKT1—obesity	1.59e-05	7.59e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—POMC—obesity	1.58e-05	7.53e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—INS—obesity	1.57e-05	7.49e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—IL6—obesity	1.57e-05	7.47e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—PIK3CA—obesity	1.55e-05	7.4e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—CCL2—obesity	1.55e-05	7.37e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IGF1—obesity	1.52e-05	7.24e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT2—obesity	1.52e-05	7.24e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MTOR—obesity	1.51e-05	7.17e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CB—obesity	1.51e-05	7.17e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MMP9—obesity	1.49e-05	7.11e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CD—obesity	1.46e-05	6.95e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MAPK8—obesity	1.45e-05	6.91e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling by GPCR—AKT1—obesity	1.45e-05	6.89e-05	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—PIK3CA—obesity	1.45e-05	6.89e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—SERPINE1—obesity	1.44e-05	6.88e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TYK2—obesity	1.4e-05	6.69e-05	CbGpPWpGaD
Remifentanil—OPRK1—GPCR downstream signaling—AKT1—obesity	1.4e-05	6.66e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—RHOA—obesity	1.39e-05	6.63e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—NOS3—obesity	1.38e-05	6.57e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3R1—obesity	1.38e-05	6.57e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—IL6—obesity	1.38e-05	6.55e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—STAT3—obesity	1.33e-05	6.32e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—PIK3CA—obesity	1.31e-05	6.25e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MMP9—obesity	1.31e-05	6.23e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MAPK8—obesity	1.27e-05	6.06e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MTOR—obesity	1.27e-05	6.06e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CB—obesity	1.27e-05	6.06e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling by GPCR—AKT1—obesity	1.27e-05	6.05e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—MYC—obesity	1.23e-05	5.87e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—TGFB1—obesity	1.23e-05	5.86e-05	CbGpPWpGaD
Remifentanil—OPRM1—GPCR downstream signaling—AKT1—obesity	1.18e-05	5.63e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—STAT3—obesity	1.16e-05	5.54e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—IL6—obesity	1.16e-05	5.54e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MMP9—obesity	1.11e-05	5.27e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—MYC—obesity	1.08e-05	5.15e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—TGFB1—obesity	1.08e-05	5.14e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MAPK8—obesity	1.08e-05	5.12e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling by GPCR—AKT1—obesity	1.07e-05	5.11e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—PIK3CA—obesity	1.05e-05	4.99e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—STAT3—obesity	9.83e-06	4.68e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—IL6—obesity	9.27e-06	4.41e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—PIK3CA—obesity	9.18e-06	4.37e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—MYC—obesity	9.13e-06	4.35e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—TGFB1—obesity	9.11e-06	4.34e-05	CbGpPWpGaD
Remifentanil—OPRD1—Signaling Pathways—AKT1—obesity	8.55e-06	4.07e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—IL6—obesity	8.12e-06	3.87e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—PIK3CA—obesity	7.75e-06	3.69e-05	CbGpPWpGaD
Remifentanil—OPRK1—Signaling Pathways—AKT1—obesity	7.5e-06	3.57e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—IL6—obesity	6.87e-06	3.27e-05	CbGpPWpGaD
Remifentanil—OPRM1—Signaling Pathways—AKT1—obesity	6.33e-06	3.02e-05	CbGpPWpGaD
